Delivery Order SPE2DB22D1106-SPE2DB25FDNB8

Award Date 11/26/24
Potential Completion Date 11/27/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDNB8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,462.96 firm-fixed-price delivery order is for the provision of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a specialty pharmaceutical product.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses a variety of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award did not utilize any set-aside designations, indicating open competition. AmerisourceBergen, as the prime contractor, is responsible for delivering the specified pharmaceutical product to support the healthcare needs of military personnel, veterans, and other federal beneficiaries through this streamlined contracting mechanism.

Generated 3/2/25, 12:48 AM